Assignee
ANTENGENE BIOLOGICS LTD
CN·0 granted patents·6 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
6 records- 0158US2025361295A1Novel anti-lilrb4 antibodies and uses thereofANTENGENE BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 0253US2024400689A1Novel anti-cd276 antibodies and the uses thereofANTENGENE BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 0353US2025368734A1Novel anti-gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereofANTENGENE BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 0452US2024052052A1Novel anti-cd24 antibodiesANTENGENE BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 0552US2025223358A1Novel anti-cd3 antibodies and uses thereofANTENGENE BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 0650US2023095569A1Antibodies and methods for treating claudin-associated diseasesANTENGENE BIOLOGICS LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →